Pediatric Intensive Care Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Kidney Int. 2009 Dec;76(12):1289-92. doi: 10.1038/ki.2009.383. Epub 2009 Sep 30.
A large percentage of patients on extracorporeal membrane oxygenation (ECMO) require continuous renal replacement therapy (CRRT) usually performed through a different venous access or by introducing a filter into the ECMO circuit. Here, we evaluated the efficacy and safety of including a CRRT machine in the circuit by connecting its inlet line after the centrifugal pump and its outlet line before the oxygenator. We tested the function of the combined system initially in a closed circuit, followed by an experimental animal study, and, finally, in a clinical trial with six children. Both machines functioned adequately and there were no significant changes in the pressures of the ECMO circuit after the introduction of the CRRT device, thus achieving the preset negative balances and normalization of the serum urea and creatinine concentrations. The mean life of the filters was about 138 h, and only one filter needed changing due to clotting. Our study shows that the introduction of a CRRT device into the ECMO circuit is a safe and effective technique that improves fluid balance, increases filter life, and does not cause complications. For these reasons, this may be a good method for performing CRRT in patients on ECMO.
很大比例的体外膜肺氧合(ECMO)患者需要持续肾脏替代治疗(CRRT),通常通过不同的静脉通路或在 ECMO 回路中引入过滤器来实现。在这里,我们通过将 CRRT 机的入口线连接到离心泵后,出口线连接到氧合器前,评估了在回路中包含 CRRT 机的疗效和安全性。我们首先在封闭回路中测试了组合系统的功能,然后进行了动物实验研究,最后在 6 名儿童的临床试验中进行了测试。两台机器均能正常运行,在引入 CRRT 设备后,ECMO 回路的压力没有明显变化,从而达到了预设的负平衡,并使血清尿素和肌酐浓度正常化。过滤器的平均寿命约为 138 小时,仅因凝血而更换了一个过滤器。我们的研究表明,在 ECMO 回路中引入 CRRT 设备是一种安全有效的技术,可改善液体平衡,延长过滤器寿命,且不会引起并发症。由于这些原因,这可能是在 ECMO 患者中进行 CRRT 的一种较好方法。